生物动力游戏:双重准MDMX/MDM2重新启动p53以击败肺腺癌的免疫技巧
Solomon Wong1, Lu Xu2, Weiming You3,4
1School of Medicine, Guangxi University, Nanning, 530004, People's Republic of China.
International journal of nanomedicine
|August 19, 2025
概括
一种新的生物纳米药物,E@MDP,通过向MDM2和MDMX,重新激活瘤抑制剂p53. 这增强了PD-1免疫检查点疗法,在肺癌模型中显示出显著的瘤回归和亡,具有良好的安全性.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 纳米医学是一种纳米医学.
背景情况:
- MDM2和MDMX蛋白质抑制瘤抑制剂p53,促进肺腺癌中的免疫逃避.
- 这种抑制限制了抗瘤免疫力和对免疫检查点抑制剂 (ICI) 的抵抗力.
研究的目的:
- 开发一种新的生物类纳米药物,E@MDP,针对MDM2和MDMX.
- 评估E@MDP在肺癌中重新激活p53并增强PD-1免疫疗法的潜力.
主要方法:
- E@MDP纳米粒子是通过黄金介导自组装和红细胞膜封装来构建的.
- 评估了物理化学性质,并在体外 (LLC细胞) 和体内 (肺腺癌小鼠模型) 测试了治疗疗效.
主要成果:
- 在体外,E@MDP恢复了p53活性 (2.46倍增加) 并促进了细胞灭绝 (3.9倍增强).
- 在体内,E@MDP通过重编程瘤免疫微环境,在与PD-1阻断相结合时显著增强瘤回归 (近2倍).
- 这种纳米药物在临床前模型中表现出了有利的安全性.
结论:
- E@MDP代表了肺癌免疫治疗的有希望的策略,克服了传统类药物的局限性.
- 生物纳米药物平台显示出治疗免疫逃避性癌症的潜力.
更多相关视频
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.4K
15:24Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
Published on: December 16, 2022
3.3K
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
